Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aziz Aiderus"'
Autor:
Jody Hazlett, Virginia Niemi, Aziz Aiderus, Katelyn Powell, Lyn Wise, Roslyn Kemp, Anita K. Dunbier
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
Abstract Background Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast
Externí odkaz:
https://doaj.org/article/1bf3059867b54fb0bf092fe3619971c0
Autor:
Aziz Aiderus, Justin Y Newberg, Liliana Guzman-Rojas, Ana M Contreras-Sandoval, Amanda L Meshey, Devin J Jones, Felipe Amaya-Manzanares, Roberto Rangel, Jerrold M Ward, Song-Choon Lee, Kenneth Hon-Kim Ban, Keith Rogers, Susan M Rogers, Luxmanan Selvanesan, Leslie A McNoe, Neal G Copeland, Nancy A Jenkins, Kenneth Y Tsai, Michael A Black, Karen M Mann, Michael B Mann
Publikováno v:
PLoS Genetics, Vol 17, Iss 8, p e1009094 (2021)
The systematic identification of genetic events driving cellular transformation and tumor progression in the absence of a highly recurrent oncogenic driver mutation is a challenge in cutaneous oncology. In cutaneous squamous cell carcinoma (cuSCC), t
Externí odkaz:
https://doaj.org/article/9ca296e0d3ca42438be6049b510b1dcf
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-15 (2018)
Abstract Background Altered cellular metabolism is a hallmark of cancer but the association between utilisation of particular metabolic pathways in tumours and patient outcome is poorly understood. We sought to investigate the association between fat
Externí odkaz:
https://doaj.org/article/0b227077b46347638d3b6c68e00fdd00
Autor:
Roslyn A. Kemp, Virginia Niemi, Lyn M. Wise, Aziz Aiderus, Anita K. Dunbier, Jody Hazlett, Katelyn Powell
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
Background Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours h
Autor:
Amanda L. Meshey, Neal G. Copeland, Ana M. Contreras-Sandoval, Michael B. Mann, Karen M. Mann, Jerrold M. Ward, Deborah A. Swing, Nancy A. Jenkins, Aziz Aiderus, Justin Y. Newberg
Publikováno v:
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 225, p 225 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 225, p 225 (2021)
Simple Summary Over the past two decades, there have been many published studies reporting high-copy SB transgenic lines in which the transposon allele includes both gene-trap and internal promoter elements to drive tumorigenesis in vivo. Cancer gene
Autor:
Karen M. Mann, Neal G. Copeland, Michael B. Mann, Deborah A. Swing, Justin Y. Newberg, Jerrold M. Ward, Nancy A. Jenkins, Aziz Aiderus, Ana M. Contreras-Sandoval, Amanda L. Meshey
A central challenge in cancer genomics is the systematic identification of single and cooperating tumor suppressor genes driving cellular transformation and tumor progression in the absence of oncogenic driver mutation(s). Multiple in vitro and in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa31d22cee717415ba8e929acf912a00
https://doi.org/10.1101/2020.08.17.254565
https://doi.org/10.1101/2020.08.17.254565
Autor:
Keith Rogers, Song Choon Lee, Ana M. Contreras-Sandoval, Devin J. Jones, Nancy A. Jenkins, Liliana Guzman-Rojas, Leslie A. McNoe, Amanda L. Meshey, Kenneth Y. Tsai, Karen M. Mann, Michael B. Mann, Aziz Aiderus, Kenneth Hon Kim Ban, Felipe Amaya-Manzanares, Justin Y. Newberg, Jerrold M. Ward, Luxmanan Selvanesan, Neal G. Copeland, Susan M. Rogers, Michael A. Black, Roberto Rangel
Publikováno v:
PLoS Genetics, Vol 17, Iss 8, p e1009094 (2021)
PLoS Genetics
PLoS Genetics
The systematic identification of genetic events driving cellular transformation and tumor progression in the absence of a highly recurrent oncogenic driver mutation is a challenge in cutaneous oncology. In cutaneous squamous cell carcinoma (cuSCC), t